---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-009712"
form_type: "8-K"
ticker: "SNGX"
cik: "0000812796"
company_name: "SOLIGENIX, INC."
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:42:22.138444+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Soligenix induces warrant exercise for up to $4.2M, issues new warrants at 150% coverage

## Summary
- Up to 703,125 existing warrants exercised at $6.00/share; gross proceeds up to ~$4.2M.
- For each exercised warrant, company issues new warrant to purchase 150% of shares, exercisable at $6.00, 5-year term.
- New warrants unregistered; company to file S-1 resale registration by July 25, 2024.
- A.G.P. receives 6% fee of gross proceeds; net proceeds for clinical development and working capital.
- Exhibit warns of potential Nasdaq delisting risk if compliance not regained.

## SEC filing metadata
- accession: 0001558370-24-009712
- form_type: 8-K
- ticker: SNGX
- cik: 0000812796
- company_name: SOLIGENIX, INC.
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/812796/000155837024009712/0001558370-24-009712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/812796/000155837024009712/sngx-20240709x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-009712
- JSON: https://secwatch.observer/filing/0001558370-24-009712.json
- Plain text: https://secwatch.observer/filing/0001558370-24-009712.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.